Skip to main content
Top
Published in: Endocrine 3/2019

01-09-2019 | Diabetic Retinopathy | Original Article

Activation of retinal Müller cells in response to glucose variability

Authors: Fabiana Picconi, Mariacristina Parravano, Francesca Sciarretta, Chiara Fulci, Michela Nali, Simona Frontoni, Monica Varano, Anna Maria Caccuri

Published in: Endocrine | Issue 3/2019

Login to get access

Abstract

Purpose

In the earliest stages of diabetic retinopathy (DR), a dysfunction of Müller cells, characterized by high levels of glial fibrillary acidic protein (GFAP), and aquaporins (AQP), has been observed. Although chronic hyperglycemia causes the activation of Müller cells, the effect of glycemic fluctuations is yet unknown. The aim of the study was to analyze the impact of glucose variability on rat retinal Müller cells (rMC-1) adapted to either normal (5 mM) or high (25 mM) glucose levels.

Methods

rMC-1 were cultured in a medium containing either 5 mM (N cells) or 25 mM of glucose (H cells) and then incubated for 96 h in a medium containing (a) low glucose (either 1–3 or 5 mM), (b) basal glucose (either 5 or 25 mM), (c) high glucose (either 25 or 45 mM), (d) basal and high glucose alternated every 24 h; (e) low- and high glucose alternated every 24 h; (f) basal glucose with episodes of low glucose for 30 min twice a day. Müller cells activation was evaluated by measuring the levels of GFAP, AQP4, and phospho-active extracellular signal-regulated kinase (pERK).

Results

Under both basal and high glucose concentrations rMC-1 were viable, but their response to glucose excursions was different. In N cells kept under normal (5 mM) glucose, a significant glial activation was measured not only in response to constant high glucose but also to alternating low/high glucose. In H cells, adapted to 25 mM glucose, a significant response was observed only after exposition to a lower (5 mM) glucose concentration.

Conclusion

Our results highlight Müller cells activation in response to glucose variability and a different susceptibility depending on the basal glucose conditions.
Literature
1.
go back to reference R. Lee, T.Y. Wong, C. Sabanayagam, Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis. 2, 17 (2015)CrossRef R. Lee, T.Y. Wong, C. Sabanayagam, Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis. 2, 17 (2015)CrossRef
2.
go back to reference S.F. Abcouwer, T.W. Gardner, Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann. N. Y. Acad. Sci. 1311, 174–190 (2014).CrossRefPubMedPubMedCentral S.F. Abcouwer, T.W. Gardner, Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann. N. Y. Acad. Sci. 1311, 174–190 (2014).CrossRefPubMedPubMedCentral
3.
go back to reference D.S. Ng, P.P. Chiang, G. Tan, C.G. Cheung et al. Retinal ganglion cell neuronal damage in diabetes and diabetic retinopathy. Clin. Exp. Ophthalmol. 44(4), 243–50 (2016)CrossRefPubMed D.S. Ng, P.P. Chiang, G. Tan, C.G. Cheung et al. Retinal ganglion cell neuronal damage in diabetes and diabetic retinopathy. Clin. Exp. Ophthalmol. 44(4), 243–50 (2016)CrossRefPubMed
4.
go back to reference A. Bringmann, P. Wiedemann, Müller Glial Cells in Retinal Disease. Ophthalmologica 227, 1–19 (2012)CrossRefPubMed A. Bringmann, P. Wiedemann, Müller Glial Cells in Retinal Disease. Ophthalmologica 227, 1–19 (2012)CrossRefPubMed
5.
go back to reference B.A. Coughlin, D.J. Feenstra, S. Mohr, Müller cells and diabetic retinopathy. Vis. Res. 139, 93–100 (2017)CrossRefPubMed B.A. Coughlin, D.J. Feenstra, S. Mohr, Müller cells and diabetic retinopathy. Vis. Res. 139, 93–100 (2017)CrossRefPubMed
6.
go back to reference S. Vujosevic, A. Micera, S. Bini, M. Berton, G. Esposito, E. Midena, Aqueous Humor Biomarkers of Müller Cell Activation in Diabetic Eyes. Invest. Ophthalmol. Vis. Sci. 56, 3913–3918 (2015).CrossRefPubMed S. Vujosevic, A. Micera, S. Bini, M. Berton, G. Esposito, E. Midena, Aqueous Humor Biomarkers of Müller Cell Activation in Diabetic Eyes. Invest. Ophthalmol. Vis. Sci. 56, 3913–3918 (2015).CrossRefPubMed
7.
go back to reference Y. Jiang, S.K. Biswas, J.J. Steinle, Serine 307 on insulin receptor substrate 1 is required for SOCS3 and TNF-α signaling in the rMC-1 cell line. Mol. Vis. 20, 1463–1470 (2014)PubMedPubMedCentral Y. Jiang, S.K. Biswas, J.J. Steinle, Serine 307 on insulin receptor substrate 1 is required for SOCS3 and TNF-α signaling in the rMC-1 cell line. Mol. Vis. 20, 1463–1470 (2014)PubMedPubMedCentral
8.
go back to reference B. Cui, J.H. Sun, F.F. Xiang, L. Liu, W.J. Li, Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response. Exp. Eye Res. 98, 37–43 (2012)CrossRefPubMed B. Cui, J.H. Sun, F.F. Xiang, L. Liu, W.J. Li, Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response. Exp. Eye Res. 98, 37–43 (2012)CrossRefPubMed
9.
go back to reference M.C. MacGregorl, L.R. Rosecan, A.M. Laties, F.M. Matschinskye, Altered Retinal Metabolism in Diabetes. J. Biol. Chem. 261(9), 4046–4051 (1986) M.C. MacGregorl, L.R. Rosecan, A.M. Laties, F.M. Matschinskye, Altered Retinal Metabolism in Diabetes. J. Biol. Chem. 261(9), 4046–4051 (1986)
10.
go back to reference Y. Ueda, A. Inui, Y. Mifune et al. The effects of high glucose condition on rat tenocytes in vitro and rat Achilles tendon in vivo. Bone Joint Res. 7(5), 362–372 (2018)CrossRefPubMedPubMedCentral Y. Ueda, A. Inui, Y. Mifune et al. The effects of high glucose condition on rat tenocytes in vitro and rat Achilles tendon in vivo. Bone Joint Res. 7(5), 362–372 (2018)CrossRefPubMedPubMedCentral
11.
go back to reference Y. Huang, Z.G. Xiong, Choosing an appropriate glucose concentration according to different cell types and experimental purposes is very important. Cell Stress Chaperons 20, 1–2 (2015)CrossRef Y. Huang, Z.G. Xiong, Choosing an appropriate glucose concentration according to different cell types and experimental purposes is very important. Cell Stress Chaperons 20, 1–2 (2015)CrossRef
12.
go back to reference V.P. Sarthy, S.J. Brodjian, K. Dutt, B.N. Kennedy, R.P. French, J.W. Crabb, Establishment and characterization of a retinal Müller cell line. Invest. Ophthalmol. Vis. Sci. 39(1), 212–6 (1998)PubMed V.P. Sarthy, S.J. Brodjian, K. Dutt, B.N. Kennedy, R.P. French, J.W. Crabb, Establishment and characterization of a retinal Müller cell line. Invest. Ophthalmol. Vis. Sci. 39(1), 212–6 (1998)PubMed
13.
go back to reference L. Quagliaro, L. Piconi, R. Assaloni, L. Martinelli, E. Motz, A. Ceriello, Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52, 2795–2804 (2003)CrossRefPubMed L. Quagliaro, L. Piconi, R. Assaloni, L. Martinelli, E. Motz, A. Ceriello, Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52, 2795–2804 (2003)CrossRefPubMed
14.
go back to reference J. Sun, Y. Xu, S. Sun, Y. Sun, X. Wang, Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: the role of mitochondrial reactive oxygen species. Mol. Cell Biochem. 343, 27–35 (2010)CrossRefPubMed J. Sun, Y. Xu, S. Sun, Y. Sun, X. Wang, Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: the role of mitochondrial reactive oxygen species. Mol. Cell Biochem. 343, 27–35 (2010)CrossRefPubMed
15.
go back to reference J. Sun, Y. Xu, H. Deng, S. Sun, Z. Dai, Y. Sun, Intermittent high glucose exacerbates the aberrant production of adiponectin and resistin through mitochondrial superoxide overproduction in adipocytes. J. Molen. 44, 179–185 (2010) J. Sun, Y. Xu, H. Deng, S. Sun, Z. Dai, Y. Sun, Intermittent high glucose exacerbates the aberrant production of adiponectin and resistin through mitochondrial superoxide overproduction in adipocytes. J. Molen. 44, 179–185 (2010)
16.
go back to reference L.Q. Sun, Y.Y. Chen, X. Wang et al. The protective effect of alpha lipoic acid on Schwann cells exposed to constant or intermittent high glucose. Biochem. Pharmacol. 84, 961–973 (2012)CrossRefPubMed L.Q. Sun, Y.Y. Chen, X. Wang et al. The protective effect of alpha lipoic acid on Schwann cells exposed to constant or intermittent high glucose. Biochem. Pharmacol. 84, 961–973 (2012)CrossRefPubMed
17.
go back to reference K.D. Kohnert, E.J. Freyse, E. Salzsieder, Glycaemic variability and pancreatic β-cell dysfunction. Curr. Diabetes Rev. 8, 345–354 (2012)CrossRefPubMed K.D. Kohnert, E.J. Freyse, E. Salzsieder, Glycaemic variability and pancreatic β-cell dysfunction. Curr. Diabetes Rev. 8, 345–354 (2012)CrossRefPubMed
18.
go back to reference K.E. Trueblood, S. Mohr, G.R. Dubyak, Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1. Am. J. Physiol. Cell Physiol. 301(5), C1213–23 (2011)CrossRefPubMedPubMedCentral K.E. Trueblood, S. Mohr, G.R. Dubyak, Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1. Am. J. Physiol. Cell Physiol. 301(5), C1213–23 (2011)CrossRefPubMedPubMedCentral
19.
go back to reference Y. Zhong, J. Li, Y. Chen, J.J. Wang, R. Ratan, S.X. Zhang, Activation of endoplasmic reticulum stress by hyperglycemia is essential for Müller cell-derived inflammatory cytokine production in diabetes. Diabetes 61(2), 492–504 (2012)CrossRefPubMedPubMedCentral Y. Zhong, J. Li, Y. Chen, J.J. Wang, R. Ratan, S.X. Zhang, Activation of endoplasmic reticulum stress by hyperglycemia is essential for Müller cell-derived inflammatory cytokine production in diabetes. Diabetes 61(2), 492–504 (2012)CrossRefPubMedPubMedCentral
21.
go back to reference F. Picconi, M. Parravano, D. Ylli et al. Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability. Acta. Diabetol 54(5), 489–497 (2017)CrossRefPubMedPubMedCentral F. Picconi, M. Parravano, D. Ylli et al. Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability. Acta. Diabetol 54(5), 489–497 (2017)CrossRefPubMedPubMedCentral
22.
go back to reference X. Ye, H. Ren, M. Zhang, Z. Sun, A.C. Jiang, G. Xu, ERK1/2 signaling pathway in the release of VEGF from Müller cells in diabetes. Invest. Ophthalmol. Vis. Sci. 53(7), 3481–3489 (2012)CrossRefPubMed X. Ye, H. Ren, M. Zhang, Z. Sun, A.C. Jiang, G. Xu, ERK1/2 signaling pathway in the release of VEGF from Müller cells in diabetes. Invest. Ophthalmol. Vis. Sci. 53(7), 3481–3489 (2012)CrossRefPubMed
23.
go back to reference A. Matteucci, L. Gaddini, M. Villa et al. Neuroprotection by rat Müller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation. Exp. Eye Res. 125, 20–9 (2014)CrossRefPubMed A. Matteucci, L. Gaddini, M. Villa et al. Neuroprotection by rat Müller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation. Exp. Eye Res. 125, 20–9 (2014)CrossRefPubMed
24.
go back to reference G. Groeger, F. Doonan, T.G. Cotter, M. Donovan, Reactive oxygen species regulate prosurvival ERK1/2 signaling and bFGF expression in gliosis within the retina. Invest. Ophthalmol. Vis. Sci. 53(10), 6645–54 (2012)CrossRefPubMed G. Groeger, F. Doonan, T.G. Cotter, M. Donovan, Reactive oxygen species regulate prosurvival ERK1/2 signaling and bFGF expression in gliosis within the retina. Invest. Ophthalmol. Vis. Sci. 53(10), 6645–54 (2012)CrossRefPubMed
25.
go back to reference A. Nose, Y. Mori, Y. Uchiyama-Tanaka et al. Regulation of glucose transporter (GLUT1) gene expression by angiotensin II in mesangial cells: involvement of HB-EGF and EGF receptor transactivation. Hypertens. Res. 26(1), 67–73 (2003)CrossRefPubMed A. Nose, Y. Mori, Y. Uchiyama-Tanaka et al. Regulation of glucose transporter (GLUT1) gene expression by angiotensin II in mesangial cells: involvement of HB-EGF and EGF receptor transactivation. Hypertens. Res. 26(1), 67–73 (2003)CrossRefPubMed
26.
go back to reference A.K. Kumagai, Glucose transport in brain and retina: implications in the management and complications of diabetes. Diabetes Metab. Res. Rev. 15(4), 261–73 (1999)CrossRefPubMed A.K. Kumagai, Glucose transport in brain and retina: implications in the management and complications of diabetes. Diabetes Metab. Res. Rev. 15(4), 261–73 (1999)CrossRefPubMed
29.
go back to reference C.H. Wong, K.B. Iskandar, S.K. Yadav, J.L. Hirpara, T. Loh, S. Pervaiz, Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS ONE 5(4), e9996 (2010)CrossRefPubMedPubMedCentral C.H. Wong, K.B. Iskandar, S.K. Yadav, J.L. Hirpara, T. Loh, S. Pervaiz, Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS ONE 5(4), e9996 (2010)CrossRefPubMedPubMedCentral
30.
go back to reference W. Zhang, J. Song, Y. Zhang et al. Intermittent high glucose-induced oxidative stress modulates retinal pigmented epithelial cell autophagy and promotes cell survival via increased HMGB1.BMC. Ophthalmol. 18, 192 (2018) W. Zhang, J. Song, Y. Zhang et al. Intermittent high glucose-induced oxidative stress modulates retinal pigmented epithelial cell autophagy and promotes cell survival via increased HMGB1.BMC. Ophthalmol. 18, 192 (2018)
31.
go back to reference L.E. Johnson, M. Larsen, M.T. Perez, Retinal adaptation to changing glycemic levels in a rat model of type 2 diabetes. PLoS ONE 8, 55456 (2013)CrossRef L.E. Johnson, M. Larsen, M.T. Perez, Retinal adaptation to changing glycemic levels in a rat model of type 2 diabetes. PLoS ONE 8, 55456 (2013)CrossRef
32.
go back to reference S.P. Marso, S.C. Bain, A. Consoli et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 375, 1834–1844 (2016)CrossRefPubMed S.P. Marso, S.C. Bain, A. Consoli et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 375, 1834–1844 (2016)CrossRefPubMed
33.
go back to reference L. Varadhan, T. Humphreys, C. Hariman, A.B. Walker, G.I. Varughese, GLP-1 agonist treatment: implications for diabetic retinopathy screening. Diabetes Res. Clin. Pract. 94, 68–71 (2011)CrossRef L. Varadhan, T. Humphreys, C. Hariman, A.B. Walker, G.I. Varughese, GLP-1 agonist treatment: implications for diabetic retinopathy screening. Diabetes Res. Clin. Pract. 94, 68–71 (2011)CrossRef
34.
go back to reference L. Varadhan, T. Humphreys, A.B. Walker, G.I. Varughese, The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy. Diabetes Res. Clin. Pract. 103, 37–39 (2014)CrossRef L. Varadhan, T. Humphreys, A.B. Walker, G.I. Varughese, The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy. Diabetes Res. Clin. Pract. 103, 37–39 (2014)CrossRef
Metadata
Title
Activation of retinal Müller cells in response to glucose variability
Authors
Fabiana Picconi
Mariacristina Parravano
Francesca Sciarretta
Chiara Fulci
Michela Nali
Simona Frontoni
Monica Varano
Anna Maria Caccuri
Publication date
01-09-2019
Publisher
Springer US
Published in
Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02017-5

Other articles of this Issue 3/2019

Endocrine 3/2019 Go to the issue

Endocrine Imaging

Uremic leontiasis ossea

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.